Browsing by Author "Wasunna-Smith, Brenda"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Publication
    Aducanumab and disease modifying treatments for Alzheimer's disease
    (Wiley, 2021-08-10) Thomas, Emily; Wasunna-Smith, Brenda; Kuruvilla, Tarun; Thomas, Emily; Wasunna-Smith, Brenda; Kuruvilla, Tarun; Medical and Dental
    Aducanumab has recently been licensed by the Food and Drug Administration (FDA) in the USA under its ‘accelerated approval’ pathway (to provide earlier access to treatments that fulfil an unmet need based on a surrogate endpoint) for treatment of Alzheimer's disease. This was a controversial decision, and the licence is subject to the outcome of further phase IV trials. Results will be eagerly anticipated, especially by the estimated 50 billion people worldwide currently living with dementia.1 The drugs success could pave the way for a new era in treatments at a time where existing therapies only offer symptomatic treatment to slow progression.
  • Thumbnail Image
    Publication
    Developing an amnestic mild cognitive impairment clinic
    (Royal College of Psychiatrists, 2025-05) Tyler, Laura; Wasunna-Smith, Brenda; Millward, Alice; Rees, Kerry; Kuruvilla, Tarun; Tyler, Laura; Wasunna-Smith, Brenda; Milward, Alice; Rees, Kerry; Kuruvilla, Tarun; Additional Professional Scientific and Technical; Medical and Dental
    No abstract available
  • Thumbnail Image
    Publication
    Optimising and Future-Proofing Dementia Care With Amnestic Mild Cognitive Impairment (aMCI) Clinics
    (Cambridge University Press, 2023-07-07) Raninga , Smit; Wasunna-Smith, Brenda; Millward, Alice; Rees, Kerry; Kuruvilla, Tarun; Raninga, Smit; Wasunna-Smith, Brenda; Millward, Alice; Rees, Kerry; Kuruvilla, Tarun; Medical and Dental; Additional Professional Scientific and Technical
    No abstract available